Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Journal of Nuclear Medicine September 2024, jnumed.124.268151; DOI: https://doi.org/10.2967/jnumed.124.268151 ...
Journal of Nuclear Medicine September 2024, jnumed.124.268145; DOI: https://doi.org/10.2967/jnumed.124.268145 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267489; DOI: https://doi.org/10.2967/jnumed.124.267489 ...
Journal of Nuclear Medicine September 2024, jnumed.124.268011; DOI: https://doi.org/10.2967/jnumed.124.268011 ...
Journal of Nuclear Medicine September 2024, jnumed.124.268797; DOI: https://doi.org/10.2967/jnumed.124.268797 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267877; DOI: https://doi.org/10.2967/jnumed.124.267877 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267624; DOI: https://doi.org/10.2967/jnumed.124.267624 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267751; DOI: https://doi.org/10.2967/jnumed.124.267751 ...
Journal of Nuclear Medicine September 2024, jnumed.124.267736; DOI: https://doi.org/10.2967/jnumed.124.267736 ...